US FDA says Lilly's weight-loss drug no longer in shortage-March 2024-www.financetom.com

US FDA says Lilly's weight-loss drug no longer in shortage

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA says Lilly's weight-loss drug no longer in shortage

Oct 2, 2024 9:46 PM

Oct 2 (Reuters) - Eli Lilly's ( LLY ) weight-loss drug

Zepbound and diabetes drug Mounjaro are no longer in shortage,

the U.S. Food and Drug Administration's website showed on

Wednesday.

Previous page： --Biden to Quadruple Tariffs on Chinese Electric Vehicles, The Wall Street Journal Reports Next page： Why Is Madison Square Garden Stock Down Thursday? (CORRECTED)

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--Biden to Quadruple Tariffs on Chinese Electric Vehicles, The Wall Street Journal Reports

May 10, 2024

11:10 AM EDT, 05/10/2024 (MT Newswires) -- Price: 168.57, Change: -3.40, Percent Change: -1.98 ...

Why Is Madison Square Garden Stock Down Thursday? (CORRECTED)

May 10, 2024

Editor’s Note: We have updated the story with the latest estimates, which translate to a revenue beat. The estimates used in the original article were outdated. Madison Square Garden Entertainment Corp. ( MSGE ) shares are trading lower after it reported third-quarter FY24 results. Revenue rose 13% Y/Y to $228.3 million, beating the analyst consensus of $227.6 million. Revenues from entertainment offerings...

--Masco Keeps Quarterly Dividend at $0.29 a Share, Payable June 10 to Shareholders of Record on May 24

May 10, 2024

11:08 AM EDT, 05/10/2024 (MT Newswires) -- Price: 71.92, Change: -0.12, Percent Change: -0.17 ...

Poet Technologies Completes $10-Million Private Placement of Share Units

May 10, 2024

11:10 AM EDT, 05/10/2024 (MT Newswires) -- POET Technologies ( POET ) on Friday said it closed its $10-million private placement of share units to two institutional investors. Poet sold 3.45 million units at $2.90 each. Each unit consists of a share and a five-year warrant to buy a share for $4.26. Proceeds will be used for general working capital...